Long-Term Survivorship Following Stereotactic Radiosurgery Alone for Brain Metastases: Risk of Intracranial Failure and Implications for Surveillance and Counseling
- 28 August 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 83 (2) , 203-209
Abstract
BACKGROUND: Historically, survival for even highly select cohorts of brain metastasis patients selected for SRS alone is P < .01) and total SRS tumor volume ≥5 cc (51% vs 25%, P < .01). On parsimonious multivariate analysis, failure before 2 yr (HR = 2.2, 95% CI: 1.2-4.3, P = .01) and total SRS tumor volume ≥5 cc (HR = 2.3, 95% CI: 1.2-4.3, P = .01) remained significant predictors of intracranial relapse beyond 2 yr. CONCLUSION: Relapse rates beyond 2 yr following SRS alone for brain metastases are low in patients who do not suffer intracranial relapse within the first 2 yr and with low-volume brain metastases, supporting a practice of less frequent screening beyond 2 yr. For remaining patients, frequent (every 3-4 mo) screening remains prudent, as the risk of intracranial failure after 2 yr remains high.Keywords
This publication has 23 references indexed in Scilit:
- Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United StatesCancer, 2012
- Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survivalJournal of Neurosurgery, 2012
- Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgeryJournal of Neuro-Oncology, 2012
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain MetastasesJournal of Clinical Oncology, 2012
- Cost-effectiveness Analysis of a Randomized Study Comparing Radiosurgery With Radiosurgery and Whole Brain Radiation Therapy in Patients With 1 to 3 Brain MetastasesAmerican Journal of Clinical Oncology, 2012
- Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 StudyJournal of Clinical Oncology, 2011
- Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialThe Lancet Oncology, 2009
- Predictors of Distant Brain Recurrence for Patients With Newly Diagnosed Brain Metastases Treated With Stereotactic Radiosurgery AloneInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain MetastasesJAMA, 2006
- Stereotactic radiosurgery for four or more intracranial metastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006